149 related articles for article (PubMed ID: 26879341)
1. Mapping the neck disability index to SF-6D in patients with chronic neck pain.
Zheng Y; Tang K; Ye L; Ai Z; Wu B
Health Qual Life Outcomes; 2016 Feb; 14():21. PubMed ID: 26879341
[TBL] [Abstract][Full Text] [Related]
2. Using the Multiple Sclerosis Impact Scale to estimate health state utility values: mapping from the MSIS-29, version 2, to the EQ-5D and the SF-6D.
Hawton A; Green C; Telford C; Zajicek J; Wright D
Value Health; 2012 Dec; 15(8):1084-91. PubMed ID: 23244811
[TBL] [Abstract][Full Text] [Related]
3. Predicting SF-6D utility scores from the neck disability index and numeric rating scales for neck and arm pain.
Carreon LY; Anderson PA; McDonough CM; Djurasovic M; Glassman SD
Spine (Phila Pa 1976); 2011 Mar; 36(6):490-4. PubMed ID: 20847713
[TBL] [Abstract][Full Text] [Related]
4. Estimating EQ-5D values from the Neck Disability Index and numeric rating scales for neck and arm pain.
Carreon LY; Bratcher KR; Das N; Nienhuis JB; Glassman SD
J Neurosurg Spine; 2014 Sep; 21(3):394-9. PubMed ID: 24905392
[TBL] [Abstract][Full Text] [Related]
5. The development of a model for translation of the Neck Disability Index to utility scores for cost-utility analysis in cervical disorders.
Richardson SS; Berven S
Spine J; 2012 Jan; 12(1):55-62. PubMed ID: 22209244
[TBL] [Abstract][Full Text] [Related]
6. Mapping the FACT-G cancer-specific quality of life instrument to the EQ-5D and SF-6D.
Teckle P; McTaggart-Cowan H; Van der Hoek K; Chia S; Melosky B; Gelmon K; Peacock S
Health Qual Life Outcomes; 2013 Dec; 11():203. PubMed ID: 24289488
[TBL] [Abstract][Full Text] [Related]
7. Mapping chronic liver disease questionnaire scores onto SF-6D utility values in patients with primary sclerosing cholangitis.
Kalaitzakis E; Benito de Valle M; Rahman M; Lindkvist B; Björnsson E; Chapman R; Kontodimopoulos N
Qual Life Res; 2016 Apr; 25(4):947-57. PubMed ID: 26471264
[TBL] [Abstract][Full Text] [Related]
8. Mapping the cancer-specific EORTC QLQ-C30 to the preference-based EQ-5D, SF-6D, and 15D instruments.
Kontodimopoulos N; Aletras VH; Paliouras D; Niakas D
Value Health; 2009; 12(8):1151-7. PubMed ID: 19558372
[TBL] [Abstract][Full Text] [Related]
9. Mapping QLQ-C30 Onto EQ-5D-5L and SF-6D-V2 in Patients With Colorectal and Breast Cancer From a Developing Country.
Yousefi M; Nahvijou A; Sari AA; Ameri H
Value Health Reg Issues; 2021 May; 24():57-66. PubMed ID: 33508752
[TBL] [Abstract][Full Text] [Related]
10. Obtaining SF-6D utilities from FACT-H&N in thyroid carcinoma patients: development and results from a mapping study.
Yang Q; Huang D; Jiang L; Tang Y; Zeng D
Front Endocrinol (Lausanne); 2023; 14():1160882. PubMed ID: 37664851
[TBL] [Abstract][Full Text] [Related]
11. Prediction of the SF-6D utility score from Lung cancer FACT-L: a mapping study in China.
Yang Q; Jiang LL; Li YF; Huang D
Health Qual Life Outcomes; 2023 Nov; 21(1):122. PubMed ID: 37964348
[TBL] [Abstract][Full Text] [Related]
12. Diabetes and quality of life: Comparing results from utility instruments and Diabetes-39.
Chen G; Iezzi A; McKie J; Khan MA; Richardson J
Diabetes Res Clin Pract; 2015 Aug; 109(2):326-33. PubMed ID: 26013567
[TBL] [Abstract][Full Text] [Related]
13. Accurately measuring the quality and effectiveness of cervical spine surgery in registry efforts: determining the most valid and responsive instruments.
Godil SS; Parker SL; Zuckerman SL; Mendenhall SK; McGirt MJ
Spine J; 2015 Jun; 15(6):1203-9. PubMed ID: 24076442
[TBL] [Abstract][Full Text] [Related]
14. Prediction of Health Utility Scores in Patients with Chronic Hepatitis C Using the Chronic Liver Disease Questionnaire-Hepatitis C Version (CLDQ-HCV).
Stepanova M; Younossi I; Racila A; Younossi ZM
Value Health; 2018 May; 21(5):612-621. PubMed ID: 29753360
[TBL] [Abstract][Full Text] [Related]
15. Mapping the disease-specific LupusQoL to the SF-6D.
Meacock R; Harrison M; McElhone K; Abbott J; Haque S; Bruce I; Teh LS
Qual Life Res; 2015 Jul; 24(7):1749-58. PubMed ID: 25510215
[TBL] [Abstract][Full Text] [Related]
16. Predicting SF-6D from the European Organization for Treatment and Research of Cancer Quality of Life Questionnaire scores in patients with colorectal cancer.
Wong CK; Lam CL; Wan YF; Rowen D
Value Health; 2013; 16(2):373-84. PubMed ID: 23538190
[TBL] [Abstract][Full Text] [Related]
17. Mapping the cancer-specific FACT-B onto the generic SF-6Dv2.
Nahvijou A; Safari H; Yousefi M; Rajabi M; Arab-Zozani M; Ameri H
Breast Cancer; 2021 Jan; 28(1):130-136. PubMed ID: 32712768
[TBL] [Abstract][Full Text] [Related]
18. Predicting the short form-6D preference-based index using the eight mean short form-36 health dimension scores: estimating preference-based health-related utilities when patient level data are not available.
Ara R; Brazier J
Value Health; 2009; 12(2):346-53. PubMed ID: 18647248
[TBL] [Abstract][Full Text] [Related]
19. Measurement properties of the norwegian version of the neck disability index in chronic neck pain.
Johansen JB; Andelic N; Bakke E; Holter EB; Mengshoel AM; Røe C
Spine (Phila Pa 1976); 2013 May; 38(10):851-6. PubMed ID: 23202354
[TBL] [Abstract][Full Text] [Related]
20. Mapping the Minnesota Living with Heart Failure Questionnaire (MLHFQ) to SF-6Dv2 in Chinese patients with heart failure.
Cong J; Zhu Y; Du J; Lin L; He Y; Zhang Q; Chye TO; Lv X; Liu W; Wu X; Ma F; Zhao X; Li Y; Long L
Health Qual Life Outcomes; 2022 Jun; 20(1):98. PubMed ID: 35725609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
